Economic burden of rotavirus disease in children under 5 years in Kazakhstan

Vaccine

Volumn 29, Issue 24, 2011, Pages 4175-4180

  Latipov, Renat ^a   Kuatbaeva, Aynagul ^b   Kristiansen, Olga ^c   Aubakirova, Saltanat ^d   Akhanaeva, Ulbosin ^e   Kristiansen, Ivar Sønbø ^a   Flem, Elmira ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b Epidemiological Station   (Kazakhstan)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d Department of Committee of Sanitary   (Kazakhstan)

^e Department of Committee of Sanitary and Epidemiological Station of Kyzyl Orda Region ^*  (Kazakhstan)

Author keywords

Cost of illness; Cost effectiveness; Diarrhea; Infectious diseases; Rotavirus

Indexed keywords

ABSENTEEISM; ADULT; ARTICLE; ASIA; CHILD; CONTROLLED STUDY; DIARRHEA; ECONOMICS; HEALTH CARE COST; HOSPITAL; HUMAN; KAZAKHSTAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PRODUCTIVITY; ROTAVIRUS; SENSITIVITY ANALYSIS; VACCINATION; VIRUS INFECTION; WORK;

CHILD, PRESCHOOL; DIARRHEA; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; KAZAKHSTAN; MALE; ROTAVIRUS INFECTIONS;

EID: 79956161162     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.03.019     Document Type: Article

References (27)

1. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12(2):304-306.
2. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354(1):11-22.
3. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354(1):23-33.
4. Black R.E., Cousens S., Johnson H.L., Lawn J.E., Rudan I., Bassani D.G., et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010, 375(9730):1969-1987.
5. Bresee J.S., Parashar U.D., Widdowson M.A., Gentsch J.R., Steele A.D., Glass R.I. Update on rotavirus vaccines. Pediatr Infect Dis J 2005, 24(11):947-952.
6. WHO Meeting of the immunization Strategic Advisory Group of Experts. April 2009-conclusions and recommendations. Weekly Epidemiol Report 2009, 84(23):213-236.
7. Tucker A.W., Haddix A.C., Bresee J.S., Holman R.C., Parashar U.D., Glass R.I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998, 279(17):1371-1376.
8. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005, 192(SUPPL.1):S133-S145.
9. Isakbaeva E.T., Musabaev E., Antil L., Rheingans R., Juraev R., Glass R.I., et al. Rotavirus disease in Uzbekistan: cost-effectiveness of a new vaccine. Vaccine 2007, 25(2):373-380.
10. Rheingans R.D., Antil L., Dreibelbis R., Podewils L.J., Bresee J.S., Parashar U.D. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis 2009, 200(SUPPL.1):S16-S27.
11. UNICEF Statistics: Kazakhstan 2009, [updated 2009 December 2009; cited] available from: http://www.unicef.org/infobycountry/kazakhstan_statistics.html.
12. WHO. WHO statistical information system (WHOSIS). WHO; [cited] available from: http://www.who.int/whosis/en/.
13. Review of National Immunization Coverage 1980-2008: Kazakhstan [database on the Internet], July 2009, Available from: http://www.who.int/immunization_monitoring/data/kaz.pdf.
14. WHO Generic protocol for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. Field test version (WHO/V&B/0215) 2002, http://wwwwhoint/vaccines-documents/DoxGen/H3DoxListhtm.
15. Interstate Statistical Committee of the Commonwealth of Independent States [database on the Internet] 2009, Available from: http://cisstat.com/eng/index.htm.
16. Agency of Statistics of the Republic of Kazakhstan [database on the Internet] 2009, Available from: http://www.old.stat.kz/index.php?lang=eng&uin=1171356504.
17. Grossman M. The human capital model. Handbook of health economics 2000, 347-408. Elsilver Science B.V., Amsterdam. A.J. Culyer, J.P. Newhouse (Eds.).
18. WHO Statistical Information System (WHOSIS) [database on the Internet]. Available from: http://www.who.int/whosis/en/.
19. Choosing intervention that are cost-effective (WHO-CHOICE). Unit costs for patient services [database on the Internet] 2000, World Health Organization, Geneva, [cited 1 March 2010].
20. The International Monetary Fund (IMF) [database on the Internet] 2009, Available from: http://www.imf.org.
21. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9(5):565-572.
22. Briggs A.H., Caxton K., Sculpher M. Decision modeling for health evaluation 2006, Oxford University press.
23. Country data [database on the Internet] 2010, World Bank, Available from: http://data.worldbank.org/.
24. Tate J.E., Rheingans R.D., O'Reilly C.E., Obonyo B., Burton D.C., Tornheim J.A., et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya. J Infect Dis 2009, 200(SUPPL.1):S76-S84.
25. Wilopo S.A., Kilgore P., Kosen S., Soenarto Y., Aminah S., Cahyono A., et al. Economic evaluation of a routine rotavirus vaccination programme in Indonesia. Vaccine 2009, 27(SUPPL.5):F67-F74.
26. Melliez H., Levybruhl D., Boelle P.Y., Dervaux B., Baron S., Yazdanpanah Y. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 2008, 26(5):706-715.
27. Flem E.T., Latipov R., Nurmatov Z.S., Xue Y., Kasymbekova K.T., Rheingans R.D. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in Kyrgyzstan. J Infect Dis 2009, 200(SUPPL.1):S195-S202.